Citius Oncology, Inc. Other Liabilities
Citius Oncology, Inc. (CTOR) had Other Liabilities of $559.01 thousand as of 2025-06-30, per its 10-Q filed 2025-08-12.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OtherLiabilities · last filed 2025-08-12
- 2025-06-30: Other Liabilities $559.01K.
- 2025-03-31: Other Liabilities $559.01K.
- 2024-12-31: Other Liabilities $559.01K.
- 2024-08-12: Other Liabilities $559.01K.
| Period end | Other Liabilities |
|---|---|
| 2025-06-30 | $559.01K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $559.01K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $559.01K 10-Q · filed 2025-02-14 |
| 2024-08-12 | $559.01K 10-K · filed 2024-12-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |